ASTRIA THERAPEUTICS

Serial Number 90751659
732

Registration Progress

Application Filed
Jun 3, 2021
Under Examination
Apr 16, 2024
Approved for Publication
Jan 31, 2024
Published for Opposition
Feb 20, 2024
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Apr 16, 2026 113 days

Trademark Image

ASTRIA THERAPEUTICS

Basic Information

Serial Number
90751659
Filing Date
June 3, 2021
Published for Opposition
February 20, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
732
Status Date
Oct 8, 2025
Application
Pending
Classes
005

Rights Holder

ASTRIA THERAPEUTICS, INC.

03
Address
22 Boston Wharf Road, 10th Floor
Boston, MA 02210

Ownership History

Catabasis Pharmaceuticals, Inc.

Original Applicant
03
Boston, MA

ASTRIA THERAPEUTICS, INC.

New Owner Before Publication #1
03
Boston, MA

ASTRIA THERAPEUTICS, INC.

Owner at Publication
03
Boston, MA

Legal Representation

Attorney
Richard Todd Armstrong

USPTO Deadlines

Next Deadline
113 days remaining
NOA E-Mailed - SOU Required
Due Date
April 16, 2026
Extension Available
Until October 16, 2026

Application History

42 events
Date Code Type Description Documents
Oct 9, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 8, 2025 EX3G S SOU EXTENSION 3 GRANTED Loading...
Oct 8, 2025 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 8, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 8, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 7, 2025 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 7, 2025 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 7, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 11, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 11, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 11, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 11, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 6, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 6, 2024 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jun 6, 2024 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Apr 16, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 4, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 20, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 31, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 31, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 17, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 20, 2023 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Apr 6, 2023 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Mar 20, 2023 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Oct 7, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Oct 7, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 7, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Aug 2, 2022 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Aug 2, 2022 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Aug 2, 2022 CNSL R SUSPENSION LETTER WRITTEN Loading...
Jul 20, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 20, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 20, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 23, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 23, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Feb 23, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 18, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 6, 2021 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Jun 16, 2021 TAEA I TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED Loading...
Jun 16, 2021 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Aug 25, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 7, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals for the treatment of allergic and inflammatory diseases and disorders; all of the foregoing do not contain cannabis, hemp, or derivatives thereof

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"